Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association

S Van Diepen, JN Katz, NM Albert, TD Henry… - Circulation, 2017 - Am Heart Assoc
Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state
of end-organ hypoperfusion that is frequently associated with multisystem organ failure …

Acute myocardial infarction in women: a scientific statement from the American Heart Association

LS Mehta, TM Beckie, HA DeVon, CL Grines… - Circulation, 2016 - Am Heart Assoc
Cardiovascular disease is the leading cause of mortality in American women. Since 1984,
the annual cardiovascular disease mortality rate has remained greater for women than men; …

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open …

M Gimbel, K Qaderdan, L Willemsen, R Hermanides… - The Lancet, 2020 - thelancet.com
Background Current guidelines recommend potent platelet inhibition with ticagrelor or
prasugrel in patients after an acute coronary syndrome. However, data about optimal …

Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients …

SS Dhruva, JS Ross, BJ Mortazavi, NC Hurley… - Jama, 2020 - jamanetwork.com
Importance Acute myocardial infarction (AMI) complicated by cardiogenic shock is
associated with substantial morbidity and mortality. Although intravascular microaxial left …

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

T Cuisset, P Deharo, J Quilici, TW Johnson… - European heart …, 2017 - academic.oup.com
Abstract Aims Newer P2Y12 blockers (prasugrel and ticagrelor) demonstrated significant
ischaemic benefit over clopidogrel after acute coronary syndrome (ACS). However, both …

Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials

G Ferrante, SV Rao, P Jüni, BR Da Costa… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The aim of this study was to provide a quantitative appraisal of the effects on
clinical outcomes of radial access for coronary interventions in patients with coronary artery …

Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients

D Cao, R Mehran, G Dangas, U Baber, S Sartori… - Journal of the American …, 2020 - jacc.org
Background Bleeding following percutaneous coronary intervention has important
prognostic implications. The Academic Research Consortium (ARC) recently proposed a list …

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart …

PT O'Gara, FG Kushner, DD Ascheim, DE Casey… - Journal of the American …, 2013 - jacc.org
1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. The current document constitutes a full revision and …

Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based …

Y Falck-Ytter, CW Francis, NA Johanson, C Curley… - Chest, 2012 - Elsevier
Background VTE is a serious, but decreasing complication following major orthopedic
surgery. This guideline focuses on optimal prophylaxis to reduce postoperative pulmonary …

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta… - Circulation, 2011 - Am Heart Assoc
Advances in antithrombotic therapy, along with an early invasive strategy, have reduced the
incidence of recurrent ischemic events and death in patients with acute coronary syndromes …